Gibbs Wealth Management Ligand Pharmaceuticals Inc Transaction History
Gibbs Wealth Management
- $442 Billion
- Q3 2025
A detailed history of Gibbs Wealth Management transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Gibbs Wealth Management holds 6,342 shares of LGND stock, worth $1.27 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
6,342
Previous 7,313
13.28%
Holding current value
$1.27 Million
Previous $831 Million
35.13%
% of portfolio
0.25%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding LGND
# of Institutions
344Shares Held
36.3MCall Options Held
19KPut Options Held
11.5K-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct15.8MShares$3.16 Billion1.4% of portfolio
-
Black Rock Inc. New York, NY2.87MShares$577 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$417 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.04MShares$209 Million0.09% of portfolio
-
Macquarie Group LTD Australia, C3752KShares$151 Million0.16% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.39B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...